http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101549667-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-005 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2013-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101549667-B1 |
| titleOfInvention | Composition for ameliorating or preventing side effects from radiation therapy and use thereof |
| abstract | The present invention relates to a composition for improving or preventing side effects due to radiation therapy comprising at least one gene selected from the group consisting of MAP / microtubule-affinity-regulated kinase gene and Raf kinase inhibitory protein gene or an inhibitor against a protein encoded by the gene Wherein the composition is used for increasing the cell activity of tumor cells and vascular endothelial cells due to a protein secreted from tumor cells due to radiation therapy for tumor cells, an increase in cell infiltration of tumor cells, an increase in cell migration of tumor cells, It is possible to suppress side effects due to radiation therapy by inhibiting an increase in wound healing of vascular endothelial cells or an increase in tubular formation of vascular endothelial cells, and thus it can be used as a chemotherapeutic adjuvant. |
| priorityDate | 2013-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 567.